Exploring the role of TRPM4 in calcium-dependent triggered activity and cardiac arrhythmias
Andy Pironet1, Frone Vandewiele1, Rudi Vennekens1
1Laboratory of Ion Channel Research, VIB Centre for Brain and Disease Research, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
Abstract:
Cardiac arrhythmias pose a major threat to a patient's health, yet prove to be often difficult to predict, prevent and treat. A key mechanism in the occurrence of arrhythmias is disturbed Ca2+ homeostasis in cardiac muscle cells. As a Ca2+-activated non-selective cation channel, TRPM4 has been linked to Ca2+-induced arrhythmias, potentially contributing to translating an increase in intracellular Ca2+ concentration into membrane depolarisation and an increase in cellular excitability. Indeed, evidence from genetically modified mice, analysis of mutations in human patients and the identification of a TRPM4 blocking compound that can be applied in vivo further underscore this hypothesis. Here, we provide an overview of these data in the context of our current understanding of Ca2+-dependent arrhythmias.
Insights
Transient Receptor Potential Melastatin 4 (TRPM4) channels are implicated in cardiac arrhythmias by disrupting calcium (Ca2+) homeostasis. TRPM4 may translate increased intracellular Ca2+ into cellular excitation, contributing to arrhythmias.
Area of Science:
- Cardiology
- Molecular Biology
- Physiology
Background:
- Cardiac arrhythmias are a significant health risk, often difficult to predict, prevent, and treat.
- Disturbed calcium (Ca2+) homeostasis in cardiac muscle cells is a key mechanism underlying arrhythmias.
- Transient Receptor Potential Melastatin 4 (TRPM4) channels are Ca2+-activated non-selective cation channels linked to Ca2+-induced arrhythmias.
Purpose of the Study:
- To review the role of TRPM4 channels in Ca2+-dependent cardiac arrhythmias.
- To explore how TRPM4 contributes to translating intracellular Ca2+ increases into membrane depolarization and cellular excitability.
Main Methods:
- Review of existing data from genetically modified mouse models.
- Analysis of human patient mutations associated with TRPM4.
- Consideration of in vivo studies using TRPM4 blocking compounds.
Main Results:
- Evidence from genetic studies in mice and humans supports TRPM4's involvement in arrhythmias.
- TRPM4 channel activity is linked to increased cellular excitability and membrane depolarization.
- Pharmacological inhibition of TRPM4 shows potential in managing arrhythmias.
Conclusions:
- TRPM4 channels play a critical role in Ca2+-dependent cardiac arrhythmias.
- Understanding TRPM4 function provides insights into arrhythmia mechanisms.
- TRPM4 represents a potential therapeutic target for treating cardiac arrhythmias.
More Related Videos
12:09Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
Published on: December 31, 2013
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Related Concept Videos
Mechanically-gated Ion Channels
G-Protein Gated Ion Channels
Sensory...
Mechanism of Cardiac Arrhythmias
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
